Early administration of anti-sars-cov-2 monoclonal antibodies prevents severe covid-19 in kidney transplant patients

HIGHLIGHTS

• who: Philippe Gatault from the LaboratoireFrance have published the Article: Early Administration of Anti-SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients, in the Journal: (JOURNAL) of 18/08/2022

SUMMARY

Received Published Kidney International Reports -, 1 COR 5.6.0 DTD EKIR2035_proof 9 September 2022 ce @@

ACRONYMS

LAY DEFINITIONS

• COVID-19: A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.